Literature DB >> 3409266

Two affinity states of M1 muscarine receptors.

L T Potter1, C A Ferrendelli, H E Hanchett.   

Abstract

1. The binding of oxotremorine-M to M1 muscarine receptors was examined by measuring competition between the agonist and 3H-pirenzepine, using rabbit hippocampal membranes suspended in 20 mM Tris buffer containing 1 mM Mn2+. 2. Both ligands interacted with a single class of receptors. The receptors could assume two affinity states for oxotremorine-M, with equal numbers of high-affinity (KH) and low-affinity (KL) sites. 3. KH interconverted reversibly to KL in the absence of divalent cations and interconverted reversibly to a state similar to KL in the presence of guanyl 5'-yl imidodiphosphate. 4. The results are compatible with a model in which a pair of receptor molecules can be stabilized by a guanine nucleotide-binding "G protein" and have one site each of KH and KL affinity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409266     DOI: 10.1007/bf00711244

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  25 in total

1.  Effect of solubilization on the distinct binding properties of muscarine receptors from rabbit hippocampus and brainstem.

Authors:  D D Flynn; L T Potter
Journal:  Mol Pharmacol       Date:  1986-09       Impact factor: 4.436

2.  Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence.

Authors:  T Kubo; A Maeda; K Sugimoto; I Akiba; A Mikami; H Takahashi; T Haga; K Haga; A Ichiyama; K Kangawa
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

3.  Two types of muscarinic response to acetylcholine in mammalian cortical neurons.

Authors:  D A McCormick; D A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

4.  Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.

Authors:  G R Luthin; B B Wolfe
Journal:  J Pharmacol Exp Ther       Date:  1984-03       Impact factor: 4.030

5.  [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.

Authors:  G R Luthin; B B Wolfe
Journal:  Mol Pharmacol       Date:  1984-09       Impact factor: 4.436

6.  Different effects of N-ethylmaleimide on M1 and M2 muscarine receptors in rat brain.

Authors:  D D Flynn; L T Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Assessment of mechanistic proposals for the binding of agonists to cardiac muscarinic receptors.

Authors:  H M Wong; M J Sole; J W Wells
Journal:  Biochemistry       Date:  1986-11-04       Impact factor: 3.162

8.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

9.  Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain.

Authors:  D C Mash; L T Potter
Journal:  Neuroscience       Date:  1986-10       Impact factor: 3.590

10.  Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections.

Authors:  D G Spencer; E Horváth; J Traber
Journal:  Brain Res       Date:  1986-08-13       Impact factor: 3.252

View more
  8 in total

1.  SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.

Authors:  J P Kan; R Steinberg; F Oury-Donat; J C Michaud; O Thurneyssen; J P Terranova; C Gueudet; J Souilhac; R Brodin; R Boigegrain
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists.

Authors:  H E Shannon; F P Bymaster; J C Hendrix; S J Quimby; C H Mitch
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

3.  Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder.

Authors:  T Hirata; A Kakizuka; F Ushikubi; I Fuse; M Okuma; S Narumiya
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

4.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors.

Authors:  R Maggio; Z Vogel; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.

Authors:  K Hidaka; S Tada; M Matsumoto; J Ohmori; Y Tasaki; T Nomura; S Usuda; T Yamaguchi
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

6.  Fluorescence changes reveal kinetic steps of muscarinic receptor-mediated modulation of phosphoinositides and Kv7.2/7.3 K+ channels.

Authors:  Jill B Jensen; John S Lyssand; Chris Hague; Bertil Hille
Journal:  J Gen Physiol       Date:  2009-04       Impact factor: 4.086

7.  Kinetics of M1 muscarinic receptor and G protein signaling to phospholipase C in living cells.

Authors:  Björn H Falkenburger; Jill B Jensen; Bertil Hille
Journal:  J Gen Physiol       Date:  2010-02       Impact factor: 4.086

8.  [11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.

Authors:  Hans Jc Buiter; Albert D Windhorst; Marc C Huisman; Maqsood Yaqub; Dirk L Knol; Abraham Fisher; Adriaan A Lammertsma; Josée E Leysen
Journal:  EJNMMI Res       Date:  2013-03-21       Impact factor: 3.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.